Published in BMC Health Serv Res on May 01, 2009
The process of recovery of people with mental illness: the perspectives of patients, family members and care providers: part 1. BMC Health Serv Res (2010) 0.76
The arts as a path to recovery. Can Fam Physician (2013) 0.75
What is recovery? A conceptual model and explication. Psychiatr Serv (2001) 3.81
Implementing evidence-based practices in routine mental health service settings. Psychiatr Serv (2001) 3.17
Validity in qualitative research. Qual Health Res (2001) 3.14
Illness management and recovery: a review of the research. Psychiatr Serv (2002) 2.48
What recovery means to us: consumers' perspectives. Community Ment Health J (2000) 2.11
What does recovery mean to you? Lessons from the recovery experience for research and practice. J Subst Abuse Treat (2007) 1.89
Restorying psychiatric disability: learning from first person recovery narratives. Psychiatr Rehabil J (2001) 1.86
Sense of self in recovery from severe mental illness. Br J Med Psychol (1992) 1.71
A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull (1988) 1.65
Relearning after damage in connectionist networks: toward a theory of rehabilitation. Brain Lang (1996) 1.52
Modeling processes in recovery from mental illness: relationships between symptoms, life satisfaction, and self-concept. J Health Soc Behav (2001) 1.45
Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull (1980) 1.45
European versus U.S. data on the course of schizophrenia. Am J Psychiatry (1991) 1.39
Chronicity in schizophrenia: revisited. Br J Psychiatry Suppl (1992) 1.32
Research on evidence-based practices: future directions in an era of recovery. Community Ment Health J (2003) 1.28
The road to recovery: where are we going and how do we get there? Empirically driven conclusions and future directions for service development and research. Subst Use Misuse (2008) 1.28
The natural history of schizophrenia in the long term. Br J Psychiatry (1980) 1.21
The varied outcomes of schizophrenia. Can J Psychiatry (1997) 1.19
How I perceive and manage my illness. Schizophr Bull (1989) 1.18
Discovering recovery. Psychiatr Rehabil J (2003) 1.13
Recovery and empowerment for people with psychiatric disabilities. Soc Work Health Care (1997) 1.09
The Maine and Vermont three-decade studies of serious mental illness. II. Longitudinal course comparisons. Br J Psychiatry (1995) 1.02
The long-term course of childhood-onset schizophrenia: a 42-year followup. Schizophr Bull (1997) 1.01
The Maine and Vermont three-decade studies of serious mental illness. I. Matched comparison of cross-sectional outcome. Br J Psychiatry (1995) 0.98
Predictors of retention in dual-focus self-help groups. Community Ment Health J (2003) 0.97
Contexts of social relationship development among assertive community treatment clients. Ment Health Serv Res (2003) 0.93
Experiencing recovery: a dimensional analysis of recovery narratives. Psychiatr Rehabil J (2001) 0.91
Therapeutic agents of assertive community treatment. Psychiatr Q (1999) 0.89
Recovery as perceived by people with schizophrenia, family members and health professionals: a grounded theory. Int J Nurs Stud (2007) 0.87
[The experience of recovery : Theoretical perspectives.]. Sante Ment Que (2002) 0.86
[Recovering after a psychosis; Opening a path? Finding one's own voice?]. Sante Ment Que (2002) 0.84
Recovery in schizophrenia: reality or mere slogan. Curr Psychiatry Rep (2005) 0.81
The lifeworld of the chronic mentally ill: analysis of 40 written personal accounts. Arch Psychiatr Nurs (1997) 0.80
Being mentally ill: a phenomenological inquiry. Arch Psychiatr Nurs (1998) 0.80
[Recovery from persons living with schizophrenia]. Perspect Infirm (2005) 0.80
[A system centered on recovery. Twelve points of reference for a comprehensive organization of services.]. Sante Ment Que (2002) 0.78
Spirituality and connectedness. Psychiatr Rehabil J (2002) 0.78
[Reassuming the power to act: the discreet dimension of real rehabilitation]. Sante Ment Que (1996) 0.78
Schizophrenic clients' experiences of power: using hermeneutic analysis. Image J Nurs Sch (1994) 0.78
Psychiatric hospitalization of adolescents for conduct disorder. Hosp Community Psychiatry (1994) 0.78
Patients' internal world experience of interacting with psychiatric nurses. Arch Psychiatr Nurs (1996) 0.77
[A system to recover.]. Sante Ment Que (2002) 0.77
How do they see themselves? Self-perception and functioning for people with chronic schizophrenia. J Psychosoc Nurs Ment Health Serv (1990) 0.77
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med (2003) 5.97
Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31
Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity (2009) 3.52
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun (2006) 2.56
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog (2008) 1.94
Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol (2002) 1.88
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67
Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity (2005) 1.66
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J Biol Chem (2005) 1.64
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol (2005) 1.61
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun (2006) 1.51
CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med (2002) 1.49
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol Microbiol (2012) 1.39
Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med (2007) 1.39
Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines. Bioconjug Chem (2005) 1.36
A theoretical and empirical analysis of context: neighbourhoods, smoking and youth. Soc Sci Med (2002) 1.36
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood (2008) 1.32
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. Infect Immun (2004) 1.31
Ontogeny and innate properties of neonatal dendritic cells. Blood (2003) 1.30
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun (2006) 1.26
A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res (2004) 1.26
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol (2007) 1.25
Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis. Schizophr Res (2008) 1.20
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. Infect Immun (2003) 1.18
The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences. Cancer Res (2012) 1.17
Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation. Blood (2004) 1.17
In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway. J Immunol (2003) 1.16
Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain. J Biol Chem (2003) 1.15
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. J Infect Dis (2004) 1.13
A qualitative study of religious practices by chronic mentally ill and their caregivers in South India. Int J Soc Psychiatry (2005) 1.12
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. Cancer Res (2007) 1.11
ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis. J Infect Dis (2010) 1.09
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol (2007) 1.08
Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J Immunol (2004) 1.06
TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help. Blood (2007) 1.04
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res (2005) 1.03
Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. J Nerv Ment Dis (2008) 1.01
Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. Cell Host Microbe (2012) 1.01
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells. J Immunol (2002) 1.01
Do quality of life, participation and environment of older adults differ according to level of activity? Health Qual Life Outcomes (2008) 1.01
Regulatory B and T cells in infections. Microbes Infect (2008) 1.01
Meaning of quality of life for older adults: importance of human functioning components. Arch Gerontol Geriatr (2008) 1.01
Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis. PLoS One (2008) 1.00
Subjective Quality-of-Life Predictors for Older Adults with Physical Disabilities. Am J Phys Med Rehabil (2008) 0.99
Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells. Biochemistry (2005) 0.98
Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector. Clin Vaccine Immunol (2007) 0.98
Virus-like particles: a new family of delivery systems. Expert Rev Vaccines (2002) 0.96
New tools for antigen delivery to the MHC class I pathway. Trends Immunol (2004) 0.96
Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids. Infect Immun (2005) 0.95
Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis. Infect Immun (2004) 0.93
Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect Immun (2002) 0.92
MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion. J Leukoc Biol (2013) 0.90
The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells. Int J Med Microbiol (2004) 0.90
The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. Int Immunol (2003) 0.89
Carbohydrate antigens: synthesis aspects and immunological applications in cancer. Mini Rev Med Chem (2006) 0.89
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles. Virology (2003) 0.88
In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells. Eur J Immunol (2002) 0.88
Adenylate cyclase toxin translocates across target cell membrane without forming a pore. Mol Microbiol (2010) 0.88
Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo. Int Immunol (2006) 0.87
Recovery as perceived by people with schizophrenia, family members and health professionals: a grounded theory. Int J Nurs Stud (2007) 0.87
Family physician enabling attitudes: a qualitative study of patient perceptions. BMC Fam Pract (2013) 0.87
Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences. Vaccine (2002) 0.87
Adaptation process, participation and depression over six months in first-stroke individuals and spouses. Clin Rehabil (2007) 0.87
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells. Cancer Res (2009) 0.86
Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. J Biol Chem (2010) 0.86
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres. J Immunol (2004) 0.86
Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes. Vaccine (2002) 0.85
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin. Int J Cancer (2011) 0.85
Calcium influx rescues adenylate cyclase-hemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores. PLoS Pathog (2012) 0.85
Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. PLoS One (2013) 0.85
The shift of Th1 to Th2 immunodominance associated with the chronicity of Mycobacterium bovis bacille Calmette-Guérin infection does not affect the memory response. J Immunol (2003) 0.85
Fetal spleen stroma drives macrophage commitment. Development (2006) 0.85
Personality characteristics and attachment in first episode psychosis: impact on social functioning. J Nerv Ment Dis (2007) 0.85
Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Int Immunol (2003) 0.85
Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer. Cancer Immunol Immunother (2013) 0.85
Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal. J Immunol (2005) 0.85
Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules. J Immunol (2007) 0.85
[Recovering after a psychosis; Opening a path? Finding one's own voice?]. Sante Ment Que (2002) 0.84
Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice. Blood (2012) 0.84
Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Glycobiology (2006) 0.84
Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells. J Virol (2006) 0.84
Training researchers in cultural psychiatry: the McGill-CIHR Strategic Training Program. Acad Psychiatry (2008) 0.84
Adaptation of wives to prostate cancer following diagnosis and 3 months after treatment: a test of family adaptation theory. Int J Nurs Stud (2006) 0.83
Assessing nurse-patient interactions from a caring perspective: report of the development and preliminary psychometric testing of the Caring Nurse--Patient Interactions Scale. Int J Nurs Stud (2004) 0.82
Enablement in health care context: a concept analysis. J Eval Clin Pract (2010) 0.82
Group CBT for early psychosis--are there still benefits one year later? Int J Group Psychother (2012) 0.82
Insight and psychosis: comparing the perspectives of patient, entourage and clinician. Int J Soc Psychiatry (2008) 0.81
Spirituality and religion in outpatients with schizophrenia: a multi-site comparative study of Switzerland, Canada, and the United States. Int J Psychiatry Med (2012) 0.81
Change in jumping to conclusions linked to change in delusions in early psychosis. Schizophr Res (2013) 0.81
Do people with a first episode of psychosis differ in personality profiles? Schizophr Res (2006) 0.81
Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant. Blood (2010) 0.81
Toward benchmarks for tertiary care for adults with severe and persistent mental disorders. Can J Psychiatry (2003) 0.80
Assessing enablement in clinical practice: a systematic review of available instruments. J Eval Clin Pract (2010) 0.80
Determinants of expressed emotion in mothers of schizophrenia patients. Psychiatry Res (2003) 0.80
[Foster home caregivers' point of view on the transformation of mental health services in Québec]. Sante Ment Que (2005) 0.80
The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells. Eur J Immunol (2011) 0.80
[Recovery from persons living with schizophrenia]. Perspect Infirm (2005) 0.80